Mass Balance Clinical Trial With TEV-56286

Clinical trial NCT06627231 · COMPLETED

Trial details

NCT number: NCT06627231
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2024-10-08
Primary completion: 2024-11-29
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.